Spyre Therapeutics, Inc. (SYRE) SEC filings
SYRE SEC filings moved a median of 0.00% by the close. SYRE SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the SYRE overview →
94 measured SYRE SEC filing events.
Where these SYRE SEC filings landedvs 94 measured SYRE SEC filing reactions
| Middle 50% of SYRE SEC filing reactions | -2.96% to +4.14% |
|---|---|
| Median reaction (to close) | 0.00% |
| Measured reactions | 94 |
Point-in-time · zero look-ahead
Half of the 94 SYRE SEC filing events with a measured close landed between -2.96% and +4.14%; 49% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Spyre Therapeutics, Inc. For: Oct 05 | SEC filing · Form 8-K | +2.69% | +2.46% | |
| Form 8-K Spyre Therapeutics, Inc. For: Sep 08 | SEC filing · Form 8-K | +1.63% | +6.71% | |
| Form 8-K Spyre Therapeutics, Inc. For: Aug 25 | SEC filing · Form 8-K | +0.51% | +1.75% | |
| Form 10-Q Spyre Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | +2.05% | -0.56% | |
| Form 8-K Spyre Therapeutics, Inc. For: Aug 04 | SEC filing · Form 8-K | +2.05% | -0.56% | |
| Form S-3ASR Spyre Therapeutics, Inc. | SEC filing · Form S-3ASR | +0.24% | +3.63% | |
| Form 8-K Spyre Therapeutics, Inc. For: Jun 15 | SEC filing · Form 8-K | +2.39% | +2.46% | |
| Form 8-K Spyre Therapeutics, Inc. For: May 29 | SEC filing · Form 8-K | -1.29% | -1.19% | |
| Form 8-K Spyre Therapeutics, Inc. For: May 27 | SEC filing · Form 8-K | -1.77% | -2.22% | |
| Form 10-Q Spyre Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | +1.60% | +1.07% | |
| Form 8-K Spyre Therapeutics, Inc. For: May 05 | SEC filing · Form 8-K | +1.60% | +1.07% | |
| Form 8-K Spyre Therapeutics, Inc. For: Apr 14 | SEC filing · Form 8-K | +0.87% | +3.83% | |
| Form 8-K Spyre Therapeutics, Inc. For: Apr 13 | SEC filing · Form 8-K | +0.16% | -5.57% | |
| Form ARS Spyre Therapeutics, Inc. For: Dec 31 | SEC filing · Form ARS | +0.16% | -5.57% | |
| Form DEF 14A Spyre Therapeutics, Inc. For: May 27 | SEC filing · Form DEF | +0.16% | -5.57% | |
| Form DEFA14A Spyre Therapeutics, Inc. | SEC filing · Form DEFA14A | +0.16% | -5.57% | |
| Form EFFECT Spyre Therapeutics, Inc. | SEC filing · Form EFFECT | +0.15% | +0.35% | |
| Form EFFECT Spyre Therapeutics, Inc. | SEC filing · Form EFFECT | +2.69% | +2.96% | |
| Form POS AM Spyre Therapeutics, Inc. | SEC filing · Form POS | +2.69% | +2.96% | |
| Form 10-K Spyre Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +2.25% | +14.25% | |
| Form 8-K Spyre Therapeutics, Inc. For: Feb 19 | SEC filing · Form 8-K | +2.25% | +14.25% | |
| Form S-3 Spyre Therapeutics, Inc. | SEC filing · Form S-3 | +2.25% | +14.25% | |
| Form S-8 Spyre Therapeutics, Inc. | SEC filing · Form S-8 | +2.25% | +14.25% | |
| Form 8-K Spyre Therapeutics, Inc. For: Jan 12 | SEC filing · Form 8-K | -1.63% | +7.19% | |
| Form 10-Q Spyre Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | -2.18% | -2.23% | |
| Form 8-K Spyre Therapeutics, Inc. For: Nov 04 | SEC filing · Form 8-K | -2.18% | -2.23% | |
| Form 8-K Spyre Therapeutics, Inc. For: Oct 13 | SEC filing · Form 8-K | +1.89% | +0.91% | |
| Form 8-K Spyre Therapeutics, Inc. For: Oct 14 | SEC filing · Form 8-K | +6.09% | +9.66% | |
| Form 10-Q Spyre Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | -0.30% | -5.45% | |
| Form 8-K Spyre Therapeutics, Inc. For: Aug 05 | SEC filing · Form 8-K | -0.30% | -5.45% | |
| Form S-8 Spyre Therapeutics, Inc. | SEC filing · Form S-8 | -0.30% | -5.45% | |
| Form 8-K Spyre Therapeutics, Inc. For: Jun 17 | SEC filing · Form 8-K | +0.95% | -9.96% | |
| Form 8-K Spyre Therapeutics, Inc. For: May 29 | SEC filing · Form 8-K | -0.45% | +7.11% | |
| Form 10-Q Spyre Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | +3.77% | +4.14% | |
| Form 8-K Spyre Therapeutics, Inc. For: May 08 | SEC filing · Form 8-K | +3.77% | +4.14% | |
| Form ARS Spyre Therapeutics, Inc. For: Dec 31 | SEC filing · Form ARS | +1.08% | -2.23% | |
| Form DEF 14A Spyre Therapeutics, Inc. For: May 29 | SEC filing · Form DEF | +1.08% | -2.23% | |
| Form DEFA14A Spyre Therapeutics, Inc. | SEC filing · Form DEFA14A | +1.08% | -2.23% | |
| Form EFFECT Spyre Therapeutics, Inc. | SEC filing · Form EFFECT | +0.82% | -1.10% | |
| Form EFFECT Spyre Therapeutics, Inc. | SEC filing · Form EFFECT | +2.74% | -1.74% | |
| Form POS AM Spyre Therapeutics, Inc. | SEC filing · Form POS | +2.74% | -1.74% | |
| Form 8-K Spyre Therapeutics, Inc. For: Feb 28 | SEC filing · Form 8-K | -0.29% | -4.18% | |
| Form 10-K Spyre Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +1.10% | +5.40% | |
| Form 8-K Spyre Therapeutics, Inc. For: Feb 27 | SEC filing · Form 8-K | +1.10% | +5.40% | |
| Form S-3 Spyre Therapeutics, Inc. | SEC filing · Form S-3 | +1.10% | +5.40% | |
| Form S-8 Spyre Therapeutics, Inc. | SEC filing · Form S-8 | +1.10% | +5.40% | |
| Form 8-K Spyre Therapeutics, Inc. For: Jan 13 | SEC filing · Form 8-K | -2.56% | -6.30% | |
| Form 8-K Spyre Therapeutics, Inc. For: Nov 18 | SEC filing · Form 8-K | +0.95% | +2.38% | |
| Form 10-K/A Spyre Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | -1.58% | -3.20% | |
| Form 10-Q/A Spyre Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | -1.58% | -3.20% | |
| Form 10-Q/A Spyre Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | -1.58% | -3.20% | |
| Form 10-Q/A Spyre Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | -1.58% | -3.20% | |
| Form 8-K Spyre Therapeutics, Inc. For: Nov 18 | SEC filing · Form 8-K | -1.58% | -3.20% | |
| Form 8-K Spyre Therapeutics, Inc. For: Nov 12 | SEC filing · Form 8-K | +0.23% | -9.66% | |
| Form 10-Q Spyre Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | +1.62% | +10.33% | |
| Form 8-K Spyre Therapeutics, Inc. For: Nov 07 | SEC filing · Form 8-K | +1.62% | +10.33% | |
| Form S-8 Spyre Therapeutics, Inc. | SEC filing · Form S-8 | +1.62% | +10.33% | |
| Form 8-K Spyre Therapeutics, Inc. For: Oct 11 | SEC filing · Form 8-K | +2.81% | +2.94% | |
| Form EFFECT Spyre Therapeutics, Inc. | SEC filing · Form EFFECT | +0.00% | +3.65% | |
| Form S-3 Spyre Therapeutics, Inc. | SEC filing · Form S-3 | +0.24% | +1.08% | |
| Form EFFECT Spyre Therapeutics, Inc. | SEC filing · Form EFFECT | -1.30% | +1.37% | |
| Form S-3 Spyre Therapeutics, Inc. | SEC filing · Form S-3 | +1.11% | +4.27% | |
| Form 8-K/A Spyre Therapeutics, Inc. For: Aug 07 | SEC filing · Form 8-K | -3.69% | -0.75% | |
| Form 10-Q Spyre Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | -3.69% | -0.75% | |
| Form 8-K Spyre Therapeutics, Inc. For: Aug 07 | SEC filing · Form 8-K | -3.69% | -0.75% | |
| Form 8-K Spyre Therapeutics, Inc. For: May 30 | SEC filing · Form 8-K | +0.81% | +1.45% | |
| Form 8-K Spyre Therapeutics, Inc. For: May 13 | SEC filing · Form 8-K | +0.40% | -6.55% | |
| Form 10-Q Spyre Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | -4.67% | -4.42% | |
| Form 8-K Spyre Therapeutics, Inc. For: May 09 | SEC filing · Form 8-K | -4.67% | -4.42% | |
| Form EFFECT Spyre Therapeutics, Inc. | SEC filing · Form EFFECT | +1.00% | -5.44% | |
| Form SEC STAFF LETTER Spyre Therapeutics, Inc. | SEC filing · Form SEC | +0.79% | -1.92% | |
| Form 8-K Spyre Therapeutics, Inc. For: Apr 23 | SEC filing · Form 8-K | +0.00% | +2.85% | |
| Form S-1 Spyre Therapeutics, Inc. | SEC filing · Form S-1 | +2.54% | -4.96% | |
| Form ARS Spyre Therapeutics, Inc. For: Dec 31 | SEC filing · Form ARS | +3.96% | +1.73% | |
| Form EFFECT Spyre Therapeutics, Inc. | SEC filing · Form EFFECT | +3.28% | -6.18% | |
| Form DEF 14A Spyre Therapeutics, Inc. For: May 13 | SEC filing · Form DEF | +3.28% | -6.18% | |
| Form POS AM Spyre Therapeutics, Inc. | SEC filing · Form POS | -0.92% | +0.00% | |
| Form S-1/A Spyre Therapeutics, Inc. | SEC filing · Form S-1 | -0.92% | +0.00% | |
| Form PRE 14A Spyre Therapeutics, Inc. For: May 13 | SEC filing · Form PRE | +0.00% | +3.84% | |
| Form 8-K Spyre Therapeutics, Inc. For: Mar 18 | SEC filing · Form 8-K | -9.19% | -16.33% | |
| Form POS AM Spyre Therapeutics, Inc. | SEC filing · Form POS | +1.28% | +9.56% | |
| Form S-1/A Spyre Therapeutics, Inc. | SEC filing · Form S-1 | +1.28% | +9.56% | |
| Form POS AM Spyre Therapeutics, Inc. | SEC filing · Form POS | +1.31% | +11.21% | |
| Form 10-K/A Spyre Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +2.68% | -0.93% | |
| Form S-1/A Spyre Therapeutics, Inc. | SEC filing · Form S-1 | -0.11% | +11.40% | |
| Form 10-K Spyre Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +2.68% | -0.93% | |
| Form 8-K Spyre Therapeutics, Inc. For: Feb 29 | SEC filing · Form 8-K | +2.68% | -0.93% | |
| Form S-8 Spyre Therapeutics, Inc. | SEC filing · Form S-8 | +2.68% | -0.93% | |
| Form 8-K Spyre Therapeutics, Inc. For: Feb 01 | SEC filing · Form 8-K | +0.00% | -1.29% | |
| Form S-1/A Spyre Therapeutics, Inc. | SEC filing · Form S-1 | +0.00% | -1.29% | |
| Form 8-K Spyre Therapeutics, Inc. For: Jan 16 | SEC filing · Form 8-K | +0.00% | +10.74% | |
| Form D Spyre Therapeutics, Inc. | SEC filing · Form D | — | +3.80% | |
| Form S-1 Spyre Therapeutics, Inc. | SEC filing · Form S-1 | +2.07% | +6.57% | |
| Form S-8 Spyre Therapeutics, Inc. | SEC filing · Form S-8 | +2.07% | +6.57% |
Keep exploring
More SYRE: earnings → · analyst actions → · SYRE overview →